Gene Yau
About Gene Yau
Gene Yau serves as the Executive Director of Corporate Development & Strategy at Nimbus Therapeutics, bringing extensive experience in corporate development and business strategy within the life sciences sector. He has held various roles in notable companies, contributing to significant transactions and strategic initiatives throughout his career.
Current Role at Nimbus Therapeutics
Gene Yau serves as the Executive Director of Corporate Development & Strategy at Nimbus Therapeutics since 2023. In this role, he is responsible for overseeing corporate strategies and development initiatives that align with the company's objectives. His leadership is focused on driving growth and innovation within the organization.
Previous Experience in Corporate Development
Prior to his current position, Gene Yau held various roles in corporate development across multiple organizations. He worked at Blueprint Medicines as Director of Business Development from 2019 to 2020. He also served as Associate Director of Corporate Development at Astellas Pharma from 2013 to 2017, and as Sr. Director of Corporate Development & Strategy at Nimbus Therapeutics from 2021 to 2023.
Educational Background
Gene Yau earned his MBA from The University of Chicago Booth School of Business, specializing in Entrepreneurship and Finance, from 2003 to 2006. He also holds a Master of Science in Biotechnology from Northwestern University, completed in 2000, and a Bachelor of Science in Biochemistry from the University of Illinois Urbana-Champaign, awarded in 1997.
Achievements in Business Development
Gene Yau has extensive experience in business development, having led 15 deals with a combined value exceeding $10 billion. He played a significant role in a $6 billion M&A transaction involving the TYK2 subsidiary to Takeda, which included $4 billion in cash. Additionally, he successfully managed a business transformation that included transitioning a company from clinical to commercial stage and orchestrating a $105 million private funding round in 2021.
Early Career and Research Experience
Gene Yau began his career as a Research Analyst at the Aaron Diamond AIDS Research Center from 1997 to 1999. He later transitioned to various roles in the pharmaceutical and biotechnology sectors, including positions at Abbott, Monsanto Company, and William Blair and Company, where he gained valuable insights into healthcare and investment banking.